Orchid Pharma Limited announced in a stock exchange filing the launch of its new drug, Cefepime-Enmetazobactam, approved for treating complicated urinary tract infections (cUTI), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP). In a landmark collaboration, Orchid Pharma has partnered with Cipla Limited to ensure widespread and rapid distribution of this breakthrough antibiotic combination across India. …